Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2014 08:18 ET | Source: ALR Technologies

The Kansas City Metropolitan Physician Association and ALR Technologies Announce Diabetes Management Partnership

RICHMOND, VA--(Marketwired - Jul 29, 2014) - ALR Technologies Inc. (OTCQB: ALRT), the chronic care medical device company, announced a commercial partnership with the Kansas City Metropolitan...
July 29, 2014 08:00 ET | Source: MELA Sciences

MELA Sciences Regains Compliance With NASDAQ Listing Requirements

IRVINGTON, N.Y., July 29, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
July 29, 2014 07:57 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Quarter 2 Financial Results; 25% Increase in Operating Profits

DUBLIN, July 29, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
July 29, 2014 07:30 ET | Source: Advaxis

Advaxis and the University of Pennsylvania Restructure Their Exclusive License Agreement

PRINCETON, N.J., July 29, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, and the University of Pennsylvania...
July 29, 2014 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Second Quarter and Six Month 2014 Financial Results and Updates Financial Guidance for 2014

Record Physician Demand Drives 27% Increase in U.S. Net Feraheme Revenues Strong Sales Growth and Disciplined Expense Management Generate Positive Operating Income Conference call scheduled for...
July 29, 2014 06:30 ET | Source: Boston Therapeutics

Boston Therapeutics Appoints Zbigniew J. Witczak, Ph.D., to Its Scientific Advisory Board

MANCHESTER, NH--(Marketwired - Jul 29, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases, has appointed...
July 29, 2014 05:00 ET | Source: Orion Oyj

Orion Group Interim Report January-June 2014

ORION CORPORATION / INTERIM REPORT / JANUARY-JUNE 2014 / 29 July 2014 at 12:00 noon EEST Orion Group Interim Report January-June 2014 Orion's net sales in January-June 2014 totalled EUR 522...
July 29, 2014 05:00 ET | Source: Orion

Orion Group Interim Report January-June 2014

ORION CORPORATION / INTERIM REPORT / JANUARY-JUNE 2014 / 29 July 2014 at 12:00 noon EEST Orion Group Interim Report January-June 2014 Orion's net sales in January-June 2014 totalled EUR 522...
July 29, 2014 05:00 ET | Source: Orion Oyj

Orion-konsernin osavuosikatsaus kaudelta 1-6/2014

ORION OYJ OSAVUOSIKATSAUS 1-6/2014 29.7.2014 klo 12:00 Orion-konsernin osavuosikatsaus kaudelta 1-6/2014 Orionin liikevaihto tammi-kesäkuulta 2014 oli...
July 29, 2014 01:15 ET | Source: Novartis Pharma AG

Novartis vaccine Bexsero® sees high uptake in first large-scale public vaccination program to help protect against devastating meningitis B

Program in Québec's Saguenay-Lac-Saint-Jean region is the first public campaign globally to offer Bexsero to all from 2 months to 20 years of age[1] More than 45,000 infants, young children and...
July 28, 2014 17:04 ET | Source: Vascular Solutions, Inc.

Vascular Solutions Comments on Justice Department Press Release Concerning Qui Tam Lawsuit Settlement Agreement

MINNEAPOLIS, July 28, 2014 (GLOBE NEWSWIRE) -- In response to a press release issued today by the Department of Justice concerning the settlement of a qui tam lawsuit, Vascular Solutions, Inc....
July 28, 2014 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Hold Second Quarter 2014 Financial Results Webcast and Conference Call

NOVATO, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will release second quarter 2014 financial results after market close on Thursday,...
July 28, 2014 12:43 ET | Source: Medtronic plc

Medtronic Receives FDA Approval for PRESTIGE® LP Cervical Disc System

The PRESTIGE® LP Cervical Disc is Medtronic's Third Clinically-Proven Artificial Cervical Disc to Receive FDA Approval MEMPHIS, TENN. - July 28, 2014 - Medtronic, Inc. (NYSE: MDT) announces that...
July 28, 2014 09:03 ET | Source: Kips Bay Medical

Kips Bay Medical Announces the First eSVS Mesh Implant by Lenox Hill Hospital of New York

MINNEAPOLIS, July 28, 2014 (GLOBE NEWSWIRE) -- Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (Nasdaq:KIPS), announced that on July 17, 2014, Lenox Hill Hospital in New York City...
July 28, 2014 09:00 ET | Source: Quidel

Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep

SAN DIEGO, CA--(Marketwired - Jul 28, 2014) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,...
July 28, 2014 08:30 ET | Source: Medtronic plc

Medtronic Completes Acquisition of Visualase, Inc.

MRI-Guided Laser Ablation Technology Adds to Surgical Technologies Product Portfolio and Broader Neuroscience Leadership Position MINNEAPOLIS - July 28, 2014 - Medtronic, Inc. (NYSE: MDT) today...
July 28, 2014 08:15 ET | Source: WomanCare Global

Woman Care Global to Bring Affordable Emergency Contraception to Women Across the United States

SAN DIEGO, July 28, 2014 (GLOBE NEWSWIRE) -- Woman Care Global (WCG) has just announced that it will bring affordable emergency contraception to women across the United States. In conjunction with...
July 28, 2014 08:00 ET | Source: ERBA Diagnostics, Inc.

ERBA Diagnostics, Inc. to Exhibit at AACC 2014 in Chicago, USA

MIAMI LAKES, Fla., July 28, 2014 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, is pleased to announce that it will be exhibiting its full...
July 28, 2014 07:30 ET | Source: Advaxis

Advaxis Receives Notice of Allowance for Cancer Immunotherapies Patent in Japan

PRINCETON, N.J., July 28, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS), a biotechnology company developing the next generation of cancer immunotherapies, announced that it has received a...
July 28, 2014 02:30 ET | Source: Veloxis Pharmaceuticals A/S

Envarsus® får EMA markedføringstilladelse til behandling af såvel nyre- som levertransplantationspatienter

Selskabsmeddelelse nr. 17/2014 Til: NASDAQ OMX Copenhagen A/S ...
July 28, 2014 02:30 ET | Source: Veloxis Pharmaceuticals A/S

Envarsus® Receives European Marketing Authorization for Treatment of Both Kidney and Liver Transplant Patients

Company Announcement no. 17/2014 To: NASDAQ OMX Copenhagen A/S ...
July 28, 2014 01:30 ET | Source: DBV Technologies S.A.

DBV Technologies : Résultats financiers du premier semestre 2014 de DBV Technologies

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Bagneux, France, le 28 Juillet 2014 - DBV...
July 28, 2014 01:15 ET | Source: Novartis Pharma AG

Alcon's Simbrinza® approved in the EU to treat patients living with glaucoma, a chronic sight-threatening eye disease

Simbrinza provides a convenient option to reduce treatment burden versus concomitant administration of single drugs Simbrinza is the only beta blocker-free formulation combining two approved...
July 28, 2014 01:08 ET | Source: MorphoSys AG

MorphoSys AG Reports Results for the First Six Months of 2014

MARTINSRIED / MUNICH, Germany, July 28, 2014 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX, OTC: MPSYY) today announced its financial results for the six months ending 30...
July 25, 2014 19:03 ET | Source: MELA Sciences

MELA Sciences Reports the Closing of Its Private Placement

IRVINGTON, N.Y., July 25, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the United States and the...
July 25, 2014 17:58 ET | Source: Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Regado Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- RGDO

NEW YORK, July 25, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Regado Biosciences, Inc. ("Regado" or the "Company") (Nasdaq:RGDO) and certain of its officers. The...
July 25, 2014 17:51 ET | Source: Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in STAAR Surgical Company of Class Action Lawsuit and Upcoming Deadline -- STAA

NEW YORK, July 25, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against STAAR Surgical Company ("STAAR" or the "Company") (Nasdaq:STAA) and certain of its officers. The...
July 25, 2014 13:30 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Schedules 2nd Quarter 2014 Investor Conference Call

WIXOM, Mich., July 25, 2014 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
July 25, 2014 10:09 ET | Source: Smoke Free Alternatives Trade Association

Smoke-Free Alternatives Trade Association Shares Vaping Industry Insight With Senate Staff Members

WASHINGTON, DC--(Marketwired - Jul 25, 2014) - The Smoke-Free Alternatives Trade Association (SFATA), the largest trade group dedicated to advocacy, awareness and education in the vapor...
July 25, 2014 08:30 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Provides Update on Status of VEN 307

NEW YORK, July 25, 2014 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB), a biopharmaceutical company developing innovative treatments for hepatitis B virus (HBV) and C....
July 25, 2014 08:16 ET | Source: Foresight 3 VCT PLC

Foresight 3 VCT PLC : Annual Financial Report

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} FORESIGHT 3 VCT PLC 2014 Highlights ...
July 24, 2014 17:17 ET | Source: MacroGenics, Inc.

MacroGenics' DART Candidate IND for Colorectal Cancer, MGD007, Cleared to Start Enrolling Patients

ROCKVILLE, Md., July 24, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical stage biopharmaceutical company focused on discovering and identifying innovative monoclonal...
July 24, 2014 17:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology

NEW YORK, July 24, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the publication of results from the long-term, randomized, active control Phase 3...
July 24, 2014 16:01 ET | Source: TESARO, Inc.

TESARO Announces Second-Quarter 2014 Operating Results

Oral Rolapitant New Drug Application (NDA) on Track for Submission to U.S. FDA Enrollment in Niraparib NOVA Trial Non-gBRCA Cohort Expected to Be Complete at Year End Enrollment in Phase...
July 24, 2014 16:01 ET | Source: The Spectranetics Corporation

Spectranetics Achieves Second Quarter 2014 Revenue of $43.6 Million

COLORADO SPRINGS, Colo., July 24, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today reported financial results for the three and six months ended June 30, 2014. Highlights of...
July 24, 2014 11:46 ET | Source: Foresight Enterprise VCT plc.

Foresight 4 VCT PLC : Annual Financial Report

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} FORESIGHT 4 VCT PLC Summary...
July 24, 2014 11:24 ET | Source: Foresight VCT PLC

Foresight VCT PLC : Annual Financial Report

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} FORESIGHT 4 VCT PLC Summary Financial...
July 24, 2014 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio to Host Conference Call to Discuss Second Quarter 2014 Financial Results

MEDFORD, N.Y., July 24, 2014 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that the...
July 24, 2014 08:27 ET | Source: Herborium Group, Inc.

Herborium Group's 2014 First Seven Months Sales Surpasses 2013 Annual Sales.

Fort Lee, New Jersey, July 24, 2014 (GLOBE NEWSWIRE) -- Fort Lee, N.J. July 24, 2014 Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics® Company...
July 24, 2014 08:00 ET | Source: MELA Sciences

MELA Sciences Announces New Study Results Demonstrating Improved Diagnostic Accuracy for Resident Dermatologists When Utilizing MelaFind Predictive Probability Information

IRVINGTON, N.Y., July 24, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
July 24, 2014 08:00 ET | Source: Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics Names Shlomo Yanai as Chairman of the Board of Directors

CARMIEL, Israel, July 24, 2014 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that it has chosen Mr. Shlomo Yanai as Chairman of the Company's Board of...
July 24, 2014 01:15 ET | Source: Novartis Pharma AG

FDA accepts Sandoz application for biosimilar filgrastim

Sandoz is the first company to announce it has filed for approval of a biologic under the biosimilars pathway created in the Biologics Price Competition and Innovation Act of 2009 (BPCIA). FDA's...
July 23, 2014 16:27 ET | Source: The Spectranetics Corporation

Spectranetics Announces FDA Clearance of Peripheral Laser Atherectomy Devices for In-Stent Restenosis

Turbo-Tandem® and Turbo Elite® are indicated to treat peripheral ISR, the only on-label products in the industry EXCITE clinical trial proves safety, efficacy of laser technology;...
July 23, 2014 16:02 ET | Source: GLG Life Tech

GLG Announces Agreement to Supply Global Food Industry Leader With Luo Han Guo

VANCOUVER, British Columbia, July 23, 2014 (GLOBE NEWSWIRE) -- GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of...
July 23, 2014 16:01 ET | Source: TriVascular Technologies, Inc.

TriVascular Technologies, Inc. to Hold 2014 Second Quarter Financial Results Conference Call on August 6

SANTA ROSA, Calif., July 23, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today announced that the Company will release 2014 second quarter financial results after market...
July 23, 2014 16:01 ET | Source: AngioDynamics

AngioDynamics Reports 2014 Fourth Quarter and Full Year Financial Results

Fourth Quarter of Fiscal 2014 Net sales increased 4% to $94.1 million; Average Daily Sales grew 7%, excluding supply agreement Q4 FY14 GAAP loss of $0.03 per share; Non-GAAP adjusted net...
July 23, 2014 13:52 ET | Source: LDR Holding Corporation

LDR Holding Corporation Announces Second Quarter 2014 Conference Call

Austin, TX, July 23, 2014 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical...
July 23, 2014 10:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Reports Results for the Second Quarter of 2014

Highlights include: A strong cash position of approximately $34 million at the end of the second quarter of 2014, following the acquisition of rights to MESUPRON®, a Phase II drug...
July 23, 2014 09:12 ET | Source: TicTocStop

TicTocStop.org is Improving the Lives of Kids with Tourette Syndrome by Lessening the Tics Associated with the Disorder; Help Them Do It During "A September to Remember"

NEW YORK, N.Y., July 23, 2014 (GLOBE NEWSWIRE) -- via PRWEB - "A SEPTEMBER TO REMEMBER" September 1st, 2014 begins TicToc Awareness Month. The foundation is closer than ever and working feverishly...
July 23, 2014 09:00 ET | Source: Kannaway LLC

Photo Release -- Bath Time: Kannaway Introduces New Cannabis Beauty DEFINED Product in Orlando

SAN DIEGO, July 23, 2014 (GLOBE NEWSWIRE) -- Kannaway, LLC, the first hemp lifestyle network marketing company to offer cannabidiol (CBD)-rich hemp botanical products, announced at their Orlando...